JG
DPLO

Jefferies Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Jefferies Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,008
Closed -$44K – 2938
2019
Q4 		$44K Buy
11,008
+7,276
+195% +$34.2K ﹤0.01% 2451
2019
Q3 		$18K Sell
3,732
-25,802
-87% -$144K ﹤0.01% 2635
2019
Q2 		$180K Buy
+29,534
New +$157K ﹤0.01% 2174
2019
Q1 		– Sell
-38,284
Closed -$515K – 2800
2018
Q4 		$515K Buy
38,284
+367
+1% +$6.19K ﹤0.01% 1454
2018
Q3 		$736K Buy
+37,917
New +$807K ﹤0.01% 1469
2018
Q2 		– Sell
-3,403
Closed -$79.3K – 2843
2018
Q1 		$69K Sell
3,403
-2,397
-41% -$55.9K ﹤0.01% 2105
2017
Q4 		$116K Buy
+5,800
New +$114K ﹤0.01% 2305
2015
Q3 		– Sell
-757
Closed -$34K – 3368
2015
Q2 		$34K Buy
+757
New +$28.5K ﹤0.01% 2534

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Jefferies Group's DPLO Position: Q1 2020 in Review

Jefferies Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 11,008 shares — an estimated $44K sold.

Jefferies Group first reported a position in DPLO in Q2 2015 and held it in 8 quarters. The position peaked at $736K in Q3 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Jefferies Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Jefferies Group sold 11,008 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $44K.
  • Jefferies Group first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 8 quarters.
  • Jefferies Group's DIPLOMAT PHARMACY, INC. position peaked at $736K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.